PTLA earnings call for the period ending December 31, 2019.
News & Analysis: Portola Pharmaceuticals
Investors ran away after the business provided preliminary full-year 2019 results.
These three small companies have the potential to make you a lot of money.
If you want to see your investment in the biotech market grow two-fold, these are the top stocks to buy.
These three healthcare companies have a lot of good things going for them.
PTLA earnings call for the period ending September 30, 2019.
What should investors think of this biotech stock and its signature drug candidate Andexxa?
With stock valuations down and out, the timing may be ripe for pharma and big biotech companies to start bargain hunting.
The company's second-quarter revenue is sparking optimism for future growth.
PTLA earnings call for the period ending June 30, 2019.